Loading...
Use of a purified reconstituted bilayer matrix in themanagement of chronic diabetic foot ulcers improvespatient outcomes vs standard of care: Results of aprospective randomised controlled multi-centre clinicaltrial
Armstrong, David G. Orgill, Dennis P. Galiano, Robert D. Glat, Paul M. Kaufman, Jarrod P. Carter, Marissa J. DiDomenico, Lawrence A. Zelen, Charles M.
Armstrong, David G.
Orgill, Dennis P.
Galiano, Robert D.
Glat, Paul M.
Kaufman, Jarrod P.
Carter, Marissa J.
DiDomenico, Lawrence A.
Zelen, Charles M.
Citations
Altmetric:
Genre
Journal article
Date
2022-01-09
Advisor
Committee member
Group
Department
Surgery
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
http://dx.doi.org/10.1111/iwj.13715
Abstract
Diabetic foot infections continue to be a major challenge for health care delivery systems. Following encouraging results from a pilot study using a novel purified reconstituted bilayer matrix (PRBM) to treat chronic diabetic foot ulcers (DFUs), we designed a prospective, multi-centre randomised trial comparing outcomes of PRBM at 12 weeks compared with a standard of care (SOC) using a collagen alginate dressing. The primary endpoint was percentage of wounds closed after 12 weeks. Secondary outcomes included assessments of complications, healing time, quality of life, and cost to closure. Forty patients were included in an intent-to-treat (ITT) and per-protocol (PP) analysis, with 39 completing the study protocol (n = 19 PRBM, n = 20 SOC). Wounds treated with PRBM were significantly more likely to close than wounds treated with SOC (ITT: 85% vs 30%, P = .0004, PP: 94% vs 30% P = .00008), healed significantly faster (mean 37 days vs 67 days for SOC, P = .002), and achieved a mean wound area reduction within 12 weeks of 96% vs 8.9% for SOC. No adverse events (AEs) directly related to PRBM treatment were reported. Mean PRBM cost of healing was $1731. Use of PRBM was safe and effective for treatment of chronic DFUs.
Description
Citation
Armstrong, DG, Orgill, DP, Galiano, RD, et al. Use of a purified reconstituted bilayer matrix in the management of chronic diabetic foot ulcers improves patient outcomes vs standard of care: Results of a prospective randomised controlled multi-centre clinical trial. Int Wound J. 2022; 19(5): 1197-1209. doi:10.1111/iwj.13715
Citation to related work
Wiley
Has part
International Wound Journal, Vol. 19, Iss. 5
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu